(34 days)
Not Found
No
The document describes a digital X-ray detector and its image processing capabilities, but there is no mention of AI or ML being used in the device itself or the associated console software. The performance studies focus on traditional image quality metrics and clinical review for substantial equivalence.
No
This device is an X-ray detector used for diagnostic imaging, not for treatment or therapy.
Yes
The device is an X-ray detector intended for digital imaging in general radiographic systems. Its output (digital X-ray images) is used for diagnostic procedures and "radiographic diagnosis".
No
The device description clearly states it is a "wired/wireless digital solid state X-ray detector that is based on flat-panel technology" and includes physical components like a scintillator and a-Si TFT sensor. It is a hardware device that captures X-ray images.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states it's for "digital imaging solution designed for general radiographic system for human anatomy." This describes an imaging device used on the patient, not a test performed on a sample taken from the patient.
- Device Description: The description details an "X-ray detector" that captures and digitalizes X-ray images. This is consistent with an imaging device.
- Lack of IVD characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.) or providing diagnostic information based on such analysis. IVDs are typically used to detect diseases, conditions, or infections by examining these types of samples.
The device is a medical imaging device used for diagnostic radiography, which is a different category of medical device than an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
1417WCC Digital Flat Panel X-Ray Detector is indicated for digital imaging solution designed for general radiographic system for human anatomy. It is intended to replace film or screen based radiographic systems in all general purpose diagnostic procedures. Not to be used for mammography.
Product codes (comma separated list FDA assigned to the subject device)
MQB
Device Description
1417WCC is a wired/wireless digital solid state X-ray detector that is based on flat-panel technology. The wireless LAN(IEEE 802.11a/g/n) communication signals images captured to the system and improves the user operability through high-speed processing. This radiographic image detector and processing unit consists of a scintillator coupled to an a-Si TFT sensor. This device needs to be integrated with a radiographic imaging system. It can be utilized to capture and digitalize X-ray images for radiographic diagnosis The RAW files can be further processed as DICOM compatible image files by separate console SW (not part of this 510k submission) for a radiographic diagnosis and analysis.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-Ray
Anatomical Site
human anatomy
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
To further demonstrate the substantial equivalency of two devices, clinical images are taken from both devices and reviewed by a licensed US radiologist to render an expert opinion. Both the test subject (1417WCC) and control group (1417WCA) are evaluated and compared by taking sample radiographs of similar age groups and anatomical structures in accordance with the test protocol of diagnostic radiography evaluation procedure.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The non-clinical test report contains the MTF, DQE and NPS test results of 1417WCC and 1417WCA by using the identical test equipment and same analysis method described by IEC 62220-1. The comparison of the MTF for 1417WCC and 1417WCA detector demonstrated that the MTF of the 1417WCA detector performed almost same with 1417WCC. Therefore, the overall resolution performance and sharpness of 1417WCC is almost same with 1417WCA. The DOE represents the ability to visualize object details of a certain size and contrast. 1417WCC demonstrated higher DQE performance than 1417WCA at various spatial frequencies and provides almost same Signal-to Noise Ratio (SNR) transfer from the input to the output of a detector as a function of frequency. At the lowest spatial frequency. 1417WCC has a DOE of 74% and that of 1417WCA is 72%. 1417WCC also exhibited NPS which has almost same performance with 1417WCA. Therefore, the image quality of 1417WCC is found to be substantially equivalent to 1417WCA at the same patient exposure.
To further demonstrate the substantial equivalency of two devices, clinical images are taken from both devices and reviewed by a licensed US radiologist to render an expert opinion. Both the test subject (1417WCC) and control group (1417WCA) are evaluated and compared by taking sample radiographs of similar age groups and anatomical structures in accordance with the test protocol of diagnostic radiography evaluation procedure.
Based on the non-clinical and clinical consideration test and the outcome of a comparative review by an expert for both devices, we can claim the substantial equivalency between 1417WCC and its predicate device, 1417WCA in terms of image quality.
After comparing a broad review of plain radiographic images taken with the 1417WCC and the 1417WCA, the images obtained with the 1417WCC are comparable or superior to the same view obtained from a similar patient with the 1417WCA. In general, both the spatial resolution and soft tissue contrast are superior using the 1417WCC. Specifically, the soft tissues on extremity films were seen with better clarity. There is no difficulty in evaluating a wide range of anatomic structures necessary to provide a correct conclusion.
Electrical, mechanical, environmental safety and performance testing according to standard IEC 60601-1: 2005 + CORR.I(2006) + CORR(2007) (Medical electrical equipment Part 1:General requirements for basic safety and essential performance) was performed, and EMC testing were conducted in accordance with standard IEC 60601-1-2:2007.
Non-clinical & Clinical considerations according to FDA Guidance for the Submissions of 510(k)'s for Solid State X-ray Imaging Devices" was performed.
All test results were satisfactory.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1680 Stationary x-ray system.
(a)
Identification. A stationary x-ray system is a permanently installed diagnostic system intended to generate and control x-rays for examination of various anatomical regions. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A radiographic contrast tray or radiology diagnostic kit intended for use with a stationary x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
JUL 1 6 2014
510(k) Summary
This summary of 510(k) safety and effectiveness information is being submitted in accordance with requirements of 21 CFR Part 807.92.
Date 510k summary prepared: June 11, 2014
Submitter's Name, address, telephone number, a contact person:
Submitter's Name : | Rayence Co., Ltd. |
---|---|
Submitter's Address: | 14, Samsung 1-ro 1-gil, Hwaseong-si, Gyeonggi-do, Korea |
Submitter's Telephone: | +82-31-8015-6459 |
Contact person: | Mr. Kee Dock Kim / Manager / +82-31-8015-6459 |
Official Correspondent: | Dave Kim (davekim@mtech-inc.net) |
(U.S. Designated agent) | |
Address: | 8310 Buffalo Speedway, Houston, TX 77025 |
Telephone: | +713-467-2607 |
Fax: | +713-583-8988 |
Name of the device, including the trade or proprietary name if applicable, the common or usual name and the classification name, if known:
1
Trade/proprietary name: | 1417WCC |
---|---|
Common Name: | Digital Flat Panel X-ray Detector |
Classification Name : | 21CFR892.1680 / Stationary x-ray system |
Product Code: | MQB |
1
Predicate Device :
Manufacturer | : Rayence Co., Ltd. |
---|---|
Device | : 1417WCA |
510(k) Number | : K130935 (Decision Date - July 2, 2013) |
Device Description :
1417WCC is a wired/wireless digital solid state X-ray detector that is based on flat-panel technology. The wireless LAN(IEEE 802.11a/g/n) communication signals images captured to the system and improves the user operability through high-speed processing. This radiographic image detector and processing unit consists of a scintillator coupled to an a-Si TFT sensor. This device needs to be integrated with a radiographic imaging system. It can be utilized to capture and digitalize X-ray images for radiographic diagnosis The RAW files can be further processed as DICOM compatible image files by separate console SW (not part of this 510k submission) for a radiographic diagnosis and analysis.
Indication for use :
1417WCC Digital Flat Panel X-Ray Detector is indicated for digital imaging solution designed for general radiographic system for human anatomy. It is intended to replace film or screen based radiographic systems in all general purpose diagnostic procedures. Not to be used for mammography.
2
1. Summary of Design Control Risk management
The 1417WCC digital X-ray detector is a modification of 1417WCA (K130935). The new device is designed with a thinner and lighter body compared to its predecessor, 1417WCA. The battery of 1417WCA was attached on the back of the device but the newly designed '1417WGC device has its battery inserted inside the new device.
In addition, a dedicated power supply (model name: RP003A) for:11417WGC is developed and added to its component list. (Optional user selection).
The risks and the hazardous impact of the device modification were analyzed with FMEA method. The specific risk control and protective measures to mitigate the risks from the modification were reviewed and implemented in the new product design phase. The overall assessment concluded that all risks and hazardous conditions identified arising from the design change were successfully mitigated and accepted.
2. Summary of the technological characteristics of the device compared to the predicate device:
The 1417WCC SSXI detector described in this 510(k) has the same indications for use and similar technical characteristics as its predicate device, 1417WCA flat panel detector, of Rayence Co., Ltd.
2.1 Detector
The mechanical design for each device is different as following.
Image /page/2/Figure/9 description: This image shows an exploded diagram of an assembly with labeled components. The components are labeled 1 through 6, corresponding to 'Carbon Plate', 'Carbon case', 'PC Sheet ass'y', 'Middle block ass'y', 'Main B'd', and 'Cap ass'y'. The image also includes text describing two configurations, '1417WCC' with dimensions 460 x 384 x 15.4 mm and a weight of 3.1 kg, and '1417WCA' with dimensions 460 x 417 x 15.9 mm and a weight of 3.9 kg.
3
3
Image /page/3/Figure/1 description: The image shows an exploded view of a device with its components labeled. The components include a carbon plate, front cover, middle block and panel, rear cover, battery pack, and handle. Each component is numbered from 1 to 6, respectively, and lines point from the numbers to the corresponding parts in the exploded view.
- 2.2 Power supply
1417WCC requires power supply (Model Name: RP003A)
1417WCC | 1417WCA | |
---|---|---|
Model Name | RP003A | |
Image: RP003A device | ||
Image: Connectors and LEDs | The power supply unit is not provided from Rayence. | |
① Power plug connector: Connect with AC power supply cord | ||
② LAN connector: Ethernet port for transmitting the image/command between detector and PC | ||
③ Link cable connector: Power connector for detector operating | ||
④ LED indicator: Four LEDs to display the status | ||
*Changeable part: Fuse T3.15 AL 250V | ||
Manufacturer | Rayence Co., Ltd. |
4
510(k) Submission - 1417WCC
Dimension | 188 X 92 X 41.5 mm | |||
---|---|---|---|---|
Weight | 0.46 kg | |||
Power | ||||
requirements | Input rate : 100~240VAC (50/60Hz) | |||
Output : Typ. 24VDC (Max 1.6A) | * Use CE or UL | |||
approved product | ||||
Min | Max | |||
Voltage | 18V | 24V | ||
Current | 1.9A |
The 1417WCC flat panel detector is equipped with a dedicated power supply (Model Name: RP003A). The electromagnetic compatibility test for the new device with the power supply has been conducted and the test report is included in this submission. The risk factors associated with the power supply such as power overload and overheating have been assessed and control measures to mitigate risks are discussed.
2.3 A/D conversion (analog-to-digital conversion)
The detector displays an image by digitizing and recording DN value of the analog electrical signal measured. The predicate device used 14 bit series to represent 16,384 values on the gray scale whereas the newly improved subject device is capable of processing both 14 and 16 bit (65,536 gray scale values) series based on the user needs and market requirements.
| Characteristic | Proposed
Rayence Co.,Ltd.
1417WCC | Predicate
Rayence Co.,Ltd.
1417WCA |
|-------------------|-----------------------------------------|------------------------------------------|
| A/D
conversion | 14 / 16 bit | 14 bit |
2.4 Recommended Generator Specification
Model | Manufacture | Specification | |||
---|---|---|---|---|---|
32kW | 40kW | 50kW | |||
CMP 200 | Communications & Power | ||||
kVp | |||||
Industries | 40-125 | 40-150 | |||
mA | 10-400 | 10-500 | 10-630 | ||
EDITOR HFe 501 | Rontgenwerk Bochum | kVp | 40-150 |
5
510(k) Submission - 1417WCC
mA | 10-630 | ||
---|---|---|---|
kVp | 40-150 | ||
UD150L-40E/40F | Shimadzu | mA | @100 kVp- 500(320) |
mA | @80 kVp- 630(400) | ||
PXR-321B | Poskom Co.,Ltd. | kVp | 125/150 |
mA | 500 |
Note: To our best knowledge, the 1417WGC detector is compatible with the X-ray generators with the specifications described above. For any questions regarding the compatibility issue for other generators which are not listed above, please contact Rayence representative.
3. Proposed Labeling- Changes in comparison to the predicate device
Item | Difference | 1417WCC | 1417WCA |
---|---|---|---|
Devi | |||
ce | |||
Labe | |||
1 | Detector | Image: Detector 1417WCC | Image: Detector 1417WCA |
Power | |||
Supply | Image: Power Supply 1417WCC | Image: Power Supply 1417WCA | |
Man | |||
ual | Indication | ||
s for Use | 1417WCC Digital Flat Panel | ||
X- | |||
Ray Detector is indicated for | |||
digital imaging solution | |||
designed for general | |||
radiographic system for | |||
human anatomy. It is intended | |||
to replace film or screen based | |||
radiographic systems in all | |||
general purpose diagnostic | |||
procedures. Not to be used for | |||
mammography. | 1417WCA Digital Flat Panel X- | ||
Ray Detector is indicated for | |||
digital imaging solution | |||
designed for general | |||
radiographic system for human | |||
anatomy. It is intended to | |||
replace film or screen based | |||
radiographic systems in all | |||
general purpose diagnostic | |||
procedures. Not to be used for | |||
mammography. | |||
Product | (page 25) | (page 25) |
6
| | Specificati
on | Pixel matrix: 3328 x 2816
Pixel area (active): 415 x 350
mm
Dimensions : 460 x 384 x 15.4
mm
Weight: 3.1 kg | Pixel matrix: 3328 x 2816
Pixel area (active): 415 x 350
mm
Dimensions : 460 x 417 x 15.9
mm
Weight: 3.9 kg |
|----------------------|-------------------|----------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------|
| | Standard | 802.11a/g/n compliance | 802.11a/g/n compliance |
| Wire
less
Spec | Peak Rate | 300Mbps | 300Mbps |
| | Frequency | 2.4 GHz / 5 GHz | 2.4 GHz / 5 GHz |
| | Bandwidth | 20MHz/40MHz | 20MHz/40MHz |
| | MIMO | 2x2 | 2x2 |
4. Summary of Performance Testing
The 1417WCC flat panel detector is a modified version of 1417WCA (K130935), FDA cleared predicate device from Rayence. Indications for use, material, form factor, performance, and safety characteristics between 1417WCC and 1417WCA are identical.
The non-clinical test report and clinical consideration report were prepared and submitted to FDA separately to demonstrate the substantial equivalency between two similar detectors. The non-clinical test report contains the MTF, DQE and NPS test results of 1417WCC and 1417WCA by using the identical test equipment and same analysis method described by IEC 62220-1. The comparison of the MTF for 1417WCC
and 1417WCA detector demonstrated that the MTF of the 1417WCA detector performed almost same with 1417WCC. Therefore, the overall resolution performance and sharpness of 1417WCC is almost same with 1417WCA. The DOE represents the ability to visualize object details of a certain size and contrast. 1417WCC demonstrated higher DQE performance than 1417WCA at various spatial frequencies and provides almost same Signal-to Noise Ratio (SNR) transfer from the input to the output of a detector as a function of frequency. At the lowest spatial frequency. 1417WCC has a DOE of 74% and that of 1417WCA is 72%. 1417WCC also exhibited NPS which has almost same performance with 1417WCA. Therefore, the image quality of 1417WCC is found to be substantially equivalent to 1417WCA at the same patient exposure.
To further demonstrate the substantial equivalency of two devices, clinical images are taken from both devices and reviewed by a licensed US radiologist to render an expert opinion. Both the test subject (1417WCC) and control group (1417WCA) are evaluated and compared by taking sample radiographs of similar age groups and anatomical structures in accordance with the test protocol of diagnostic radiography evaluation procedure.
7
7
Based on the non-clinical and clinical consideration test and the outcome of a comparative review by an expert for both devices, we can claim the substantial equivalency between 1417WCC and its predicate device, 1417WCA in terms of image quality.
After comparing a broad review of plain radiographic images taken with the 1417WCC and the 1417WCA, the images obtained with the 1417WCC are comparable or superior to the same view obtained from a similar patient with the 1417WCA. In general, both the spatial resolution and soft tissue contrast are superior using the 1417WCC. Specifically, the soft tissues on extremity films were seen with better clarity. There is no difficulty in evaluating a wide range of anatomic structures necessary to provide a correct conclusion.
The manufacturing facility is in conformance with the design control procedure requirements and the relevant EPRC standards as specified in 21 CFR 802.30 and the records are available for review.
5. Summary for any testing in the submission:
Electrical, mechanical, environmental safety and performance testing according to standard IEC 60601-1: 2005 + CORR.I(2006) + CORR(2007) (Medical electrical equipment Part 1:General requirements for basic safety and essential performance) was performed, and EMC testing were conducted in accordance with standard IEC 60601-1-2:2007.
Non-clinical & Clinical considerations according to FDA Guidance for the Submissions of 510(k)'s for Solid State X-ray Imaging Devices" was performed.
All test results were satisfactory.
6. Conclusions:
In accordance with the Federal Food, Drug and Cosmetic Act, 21 CFR Part 807 and based on the information provided in this premarket notification Rayence Co., Ltd. concludes that 1417WCC is safe and effective and substantially equivalent in comparison with 1417WCA, the predicate device as described herein.
8
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
July 16, 2014
Rayence Co., Ltd. % Mr. Dave Kim Medical Device Regulatory Affairs 8310 Buffalo Speedway HOUSTON TX 77025
Re: K141566
Trade/Device Name: Solid State X-ray Imaging Device, Digital Flat Panel X-ray Detector, 1417wcc Regulation Number: 21 CFR 892.1680 Regulation Name: Stationary x-ray system Regulatory Class: II Product Code: MQB Dated: June 12, 2014
Received: June 16, 2014
Dear Mr. Kim:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
9
Page 2—Mr. Kim
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Smh?)
for
Janine M. Morris Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
10
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: December 31, 2013 See PRA Statement on last page.
510(k) Number (if known) K141566
Device Name
1417WCC Digital Flat Panel X-Ray Detector
Indications for Use (Describe)
1417WCC Digital Flat Panel X-Ray Detector is indical imaging solution designed for general radiographic system for human anatomy. It is intended to replace film or screen based radiographic systems in all general purpose diagnostic procedures. Not to be used for mammography.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 807 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signalure)
$\left(m,7\right)$
11
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."